Tweet Archive for February 2016 « page 12
RT @MelanomaReAlli: #Immunotherapy holds promise in the realm of combination therapies. Learn more here. ow.ly/XvJGm
RT @MelanomaReAlli: Understanding Immunotherapy: What is PD-1? ow.ly/Yt9Ec
Will #sunscreens available in Europe for more than a decade be approved by the #FDA? #skincancer
New Sunscreens and the Precautionary Principle https://t.co/uEI2z2fNn1
— JAMA Dermatology (@JAMADerm) February 19, 2016
This is #IMCASAcademy! @imcascongress sessions from the confort of your home/office and share experience #SoME #hcsm
Did you know it's only possible to see 15% of the #imcas2016 content? Catch up on missed sessions with #IMCASAcademy https://t.co/XIcT5CZVzL
— IMCAS Academy (@imcasacademy) January 29, 2016
RT @BodyLanguage_FR: Nouvelle plateforme #e-learning #ImcasAcademy dédiée à la #médecineesthétique
imcas.com/en/academy
https://t.co/luk…
The Vitiligo Noticeability Scale (VNS) #dermatology
Validation of the #Vitiligo Noticeability Scale: a patient-reported outcome measure https://t.co/0OkZsnIs5K #BJD pic.twitter.com/Z7BIOfrI71
— BJD (@BrJDermatol) February 16, 2016
RT @anneklassen: Outcomes of Breast Reconstruction After Mastectomy Using Tissue Expander & Implant Reconstruction: Bigger is Better https:…
RT @mchrysopoulo: Agree 100% @DJLStudios. No evidence for efficacy. All marketing hype. #VampireLift #PlasticSurgery @OlivierBranford https…
#vampire breast lift = zero evidence #nodatanotrust #EvidenceNotOpinion
#vampire breast lift part of #Oscar gift bag? Celebrity endorsement does not equal safety #doyourhomework https://t.co/QfxrCvWjqy
— Dustin Lang (@DJLStudios) February 10, 2016
RT @prsjournal: Looking forward to @drkarenhorton‘s video discussion for the April 2016 issue of @PRSjournal! #ILookLikeASurgeon https://t…